Treatment of anxiety/depressive conditions in the elderly: a double-blind comparative study of Motival and amitriptyline.
A double-blind two-group comparison of fluphenazine/nortriptyline (F/N) with amitriptyline in 72 patients aged 65 or over suffering from mixed states of anxiety and depression, each treated for four weeks, showed F/N to be significantly superior to amitriptyline by Day 7 in terms of patients' self-ratings and clinicians' ratings. Patients' preference for F/N was even more pronounced by Day 28 (P less than 0.001), when the improvement in symptoms relating to depression was rated by the clinicians as significantly greater for the patients receiving F/N (P less than 0.025). The incidence of drowsiness was significantly greater (P less than 0.05) in the amitriptyline group than the F/N group. The implications of these results for the treatment of emotional disturbances in the elderly are discussed.
D000368:Aged; D000639:Amitriptyline / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005476:Fluphenazine / Q000627:therapeutic use*; D006801:Humans; D009661:Nortriptyline / Q000627:therapeutic use*
D004338:Drug Combinations; D000639:Amitriptyline; D009661:Nortriptyline; D005476:Fluphenazine